Plunkett Research Online: Sanofi SA

SANOFI SA (SNY:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regener.....



Sanofi SA
Ticker: SNY
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 33-1-53-77-40-00
Fax:
Address: 46, Avenue de la Great Army
Paris, 75017 France

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Development & Manufacturing
Pharmaceuticals
Research
Development
Vaccines
Diabetes
Cardiovascular
Specialty Care
Contacts Description
Olivier CharmeilCEO/Executive VP, Divisional
Francois-Xavier RogerCFO/Executive VP
See More
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regener.....See More See More

Auditor: PRICEWATERHOUSECOOPERS AUDIT
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202520242023202220212020
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (EUR)Bonus (EUR)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: